|
UCSF POLICY
UCSF GUIDELINES
UCSF Guidelines on Conflict of Interest are reproduced below in their
entirety. These guidelines supplement federal regulations, state laws,
and UC policies.
UCSF GUIDELINES ON CONFLICT OF INTEREST
PERTAINING TO RECEIVING/DISBURSING RESEARCH FUNDS
1. When a faculty member accepts a full time appointment at the University
of California it is understood that he or she will accord the University
his or her primary professional effort and will arrange outside professional
obligations, financial interests, and activities so as not to conflict
or interfere with this commitment to the University.
2. Faculty with a management or a financial interest or relationship in
a commercial entity that could pose a real or potential conflict of interest
will disclose that relationship to the Department Chair.
3. A potential conflict of interest exists when a faculty member:
A. Receives research funding from an entity, and he/she or his/her
spouse or dependent child:
- serves as a director, officer, partner, trustee, employee,
or holds a position of management with the entity
funding his/her research;
- has an investment (including, but not limited to, stock
options) in this entity;
- receives income, including salary, which
is not paid through the University, or consulting
fees from this entity;
- has received personal gifts of $50 or more from this
entity; or
- has an outstanding loan with this entity;
OR
B. Receives research funding from PHS or NSF and he/she, or his/her
spouse or dependent child has a financial relationship valued
at over $10,000 in monetary value or 5% equity in a company which
would reasonably appear to be related to his/her research.
4. A potential conflict of interest exists if an investigator disburses
research funds to an entity in which he/she, or his/her spouse or dependent
child has a financial interest or relationship.
5. All potential conflicts of interest shall be reviewed by an independent
substantive review committee known at UCSF as the Chancellor's Conflict
of Interest Advisory Committee, prior to acceptance/disbursement of any
research funds.
6. The Chancellor's Conflict of Interest Advisory Committee shall review
all sponsored research agreements, research gifts or consulting agreements
where there is a potential conflict of interest, using the definitions
set forth in University
Policy on Disclosure of Financial Interest in Private Sponsors of Research (dated
April, 1984) or in accordance with the University
of California Policy on Disclosure of Financial Interests and Management
of Conflicts of Interest Related to Sponsored Projects. Each disclosure
shall be reviewed on a case by case basis using the University
of California Guidelines on University-Industry Relations, issued in
May, 1989 as a guide and paying specific attention to the following criteria:
an open academic environment is maintained, freedom to publish and discuss
research results is not compromised, and the intellectual freedom of students
is protected; fair licensing practices are employed; and the use of University
facilities and resources is appropriate.
7. In situations where a faculty member has a conflict of interest in
the research, and this conflict is deemed acceptable by the University,
the faculty member shall disclose his or her relationship with the sponsor
in any publications emanating from this research and in public discussions
of the research.
8. Faculty and administrators shall withdraw from any decisions by the
University or the sponsor affecting the University in regard to a company
in which they or their family members have a financial interest or relationship.
9. Any faculty member who serves on the Board of Directors of a for-profit
company shall not be permitted to receive research funding from that company.
This section does not apply to contracts and grants under the federal SBIR/STTR
programs.
10. Any faculty member who has an investment in a company, which is more
than five percent (5%) of the total value of the company, shall not be
permitted to receive research funding from that company. This section does
not apply to contracts and grants under the federal SBIR/STTR programs.
11. Faculty who have, or participate in, a privately sponsored clinical
study shall not concurrently receive any compensation from the sponsor,
including honoraria and consulting fees, during the course of the study.
In addition, they shall not have any investment in, or serve in a decision-making
capacity for (such as service on the Board of Directors or management committee),
or be an officer or employee of the company sponsoring the study.
12. For purposes of financial disclosure in conjunction with a research
project, professional witness fees are considered to be income and need
to be disclosed by the faculty member.
Effective 1994; Revised March 1, 2004
|